{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:16:04Z","timestamp":1785168964527,"version":"3.55.0"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1111\/bjh.14557","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T21:25:33Z","timestamp":1489526733000},"page":"414-422","source":"Crossref","is-referenced-by-count":22,"title":["Measurement of<i>BCR-ABL1<\/i>by RT-qPCR in chronic myeloid leukaemia: findings from an International EQA Programme"],"prefix":"10.1111","volume":"177","author":[{"given":"Stuart","family":"Scott","sequence":"first","affiliation":[{"name":"UKNEQAS for Leucocyte Immunophenotyping; Sheffield Teaching Hospitals; Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Travis","sequence":"additional","affiliation":[{"name":"UKNEQAS for Leucocyte Immunophenotyping; Sheffield Teaching Hospitals; Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Whitby","sequence":"additional","affiliation":[{"name":"UKNEQAS for Leucocyte Immunophenotyping; Sheffield Teaching Hospitals; Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bainbridge","sequence":"additional","affiliation":[{"name":"Biostatistics Center; Duke Human Vaccine Institute; Duke University Medical Center; Durham NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C. P.","family":"Cross","sequence":"additional","affiliation":[{"name":"Wessex Regional Genetics Laboratory; Salisbury District Hospital; Salisbury UK"},{"name":"Faculty of Medicine; University of Southampton; Southampton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barnett","sequence":"additional","affiliation":[{"name":"UKNEQAS for Leucocyte Immunophenotyping; Sheffield Teaching Hospitals; Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"10.1111\/bjh.14557-BIB0001|bjh14557-cit-0001","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1182\/blood.V124.21.4540.4540","article-title":"Exceeding MR5.0 sensitivity in routine BCR-ABL1 analysis using multiplex digital PCR","volume":"124","author":"Andersen","year":"2014","journal-title":"Blood"},{"key":"10.1111\/bjh.14557-BIB0002|bjh14557-cit-0002","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"key":"10.1111\/bjh.14557-BIB0003|bjh14557-cit-0003","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1182\/blood-2008-04-150680","article-title":"Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials","volume":"112","author":"Branford","year":"2008","journal-title":"Blood"},{"key":"10.1111\/bjh.14557-BIB0004|bjh14557-cit-0004","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.beha.2009.04.001","article-title":"Standardisation of molecular monitoring for chronic myeloid leukaemia","volume":"22","author":"Cross","year":"2009","journal-title":"Best Practice & Research. Clinical Haematology"},{"key":"10.1111\/bjh.14557-BIB0005|bjh14557-cit-0005","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1038\/leu.2016.90","article-title":"Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale","volume":"30","author":"Cross","year":"2016","journal-title":"Leukemia"},{"key":"10.1111\/bjh.14557-BIB0006|bjh14557-cit-0006","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2141.2011.08603.x","article-title":"Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia","volume":"153","author":"Foroni","year":"2011","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.14557-BIB0007|bjh14557-cit-0007","volume-title":"Practical Statistics for Field Biology","author":"Fowler","year":"1998","edition":"2"},{"key":"10.1111\/bjh.14557-BIB0008|bjh14557-cit-0008","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"Hughes","year":"2006","journal-title":"Blood"},{"key":"10.1111\/bjh.14557-BIB0009|bjh14557-cit-0009","unstructured":"ISO 1998 Accuracy (trueness and precision) of measurement methods and results International Standard Organisation Geneva"},{"key":"10.1111\/bjh.14557-BIB0010|bjh14557-cit-0010","unstructured":"ISO 2010 Conformity assessment - General requirements for proficiency testing International Standard Organisation Geneva"},{"key":"10.1111\/bjh.14557-BIB0011|bjh14557-cit-0011","unstructured":"ISO 2012 Medical laboratories - Requirements for quality and competence International Standard Organisation Geneva"},{"key":"10.1111\/bjh.14557-BIB0012|bjh14557-cit-0012","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jmoldx.2013.10.007","article-title":"Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR","volume":"16","author":"Jennings","year":"2014","journal-title":"The Journal of Molecular Diagnostics"},{"key":"10.1111\/bjh.14557-BIB0013|bjh14557-cit-0013","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/ijlh.12556","article-title":"A novel approach for BCR-ABL1 standardization to improve International Scale estimation","volume":"38","author":"Maes","year":"2016","journal-title":"International Journal of Laboratory Hematology"},{"key":"10.1111\/bjh.14557-BIB0014|bjh14557-cit-0014","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ajh.24120","article-title":"Age and dPCR can predict relapse in CML patients who discontinued imatinib: the ISAV study","volume":"90","author":"Mori","year":"2015","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.14557-BIB0015|bjh14557-cit-0015","first-page":"1013","article-title":"Chromosome studies in human leukemia. II. Chronic granulocytic leukemia","volume":"27","author":"Nowell","year":"1961","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1111\/bjh.14557-BIB0016|bjh14557-cit-0016","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/bjh.14557-BIB0017|bjh14557-cit-0017","unstructured":"Osborne , J. 2002 Notes on the use of data transformations Practical Assessment, Research & Evaluation http:\/\/pareonline.net\/getvn.asp?v=8&n=6"},{"key":"10.1111\/bjh.14557-BIB0018|bjh14557-cit-0018","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2307\/1165280","article-title":"Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models","volume":"23","author":"Singer","year":"1998","journal-title":"Journal of Educational and Behavioral Statistics"},{"key":"10.1111\/bjh.14557-BIB0019|bjh14557-cit-0019","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1182\/blood-2010-06-291641","article-title":"Establishment of the first World Health Organization International Genetic Reference Panel\u00a0for quantitation of BCR-ABL mRNA","volume":"116","author":"White","year":"2010","journal-title":"Blood"},{"key":"10.1111\/bjh.14557-BIB0020|bjh14557-cit-0020","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jaoac\/90.2.582","article-title":"Calculation of measurement uncertainty in quantitative analysis of genetically modified organisms using intermediate precision-a practical approach","volume":"90","author":"Zel","year":"2007","journal-title":"Journal of AOAC International"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.14557","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjh.14557\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T08:23:01Z","timestamp":1625386981000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.14557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1111\/bjh.14557","archive":["Portico"],"relation":{},"ISSN":["0007-1048"],"issn-type":[{"value":"0007-1048","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,14]]}}}